Vivos Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of VVOS for the last quarter is 4.05 M USD, and it's 18.57% higher compared to the previous quarter. The net income of Q2 24 is -1.93 M USD.